摘要
目的 探讨粪便隐血及肿瘤标志物联合检验在诊断结直肠癌中的应用价值。方法 选取2020年1月-2022年12月广州市番禺区康复医院接诊的疑似结直肠癌患者100例,对所有就诊患者进行粪便隐血、肿瘤标志物检验及联合检验,对检验结果进行分析。结果 确诊者95例,确诊结直肠癌患者的CA24-2、CA19-9、CEA水平相比未确诊人群均明显更高(P<0.05);联合检测检出率、灵敏度、特异性分别为98.00%、98.41%、97.30%,联合检验的诊断效能明显高于单一检验方式(P<0.05)。结论 粪便隐血及肿瘤标志物联合检验方式相比单一检验,对结直肠癌的诊断效果更高,值得在临床中推广应用。
Objective To explore application value of combined detection of fecal occult blood and tumor marker in diagnosis of colorectal cancer.Methods The paper chose 100 suspected colorectal cancer patients in Guangzhou City Panyu District Rehabilitation Hospital from January 2020 to December 2022,carried out combined detection of fecal occult blood,tumor marker for all patients,and analyzed test results.Results There were 95 confirmed cases,levels of CA24-2,CA19-9,and CEA of patients with confirmed colorectal cancer were significantly higher than undiagnosed cases,P<0.05.Combined detection:detection rate,sensitivity,and specificity was 98.00%,98.41%,and 97.30%respectively.Diagnostic effect of combined detection was significantly higher than single detection method,P<0.05.Conclusion Combined detection method of fecal occult blood and tumor markers can achieve higher diagnostic effect on colorectal cancer than single testing,which is worthy of promotion and application in clinical practice.
作者
梁嘉琪
袁静铟
赖玉虹
钟展图
LIANG Jiaqi;YUAN Jingyin;LAI Yuhong;ZHONG Zhantu(Laboratory Department,Guangzhou City Panyu District Health Management Center(Guangzhou Panyu Rehabilitation Hospital),Guangzhou,Guangdong,511400)
出处
《智慧健康》
2024年第4期114-117,共4页
Smart Healthcare
关键词
结直肠癌
肿瘤标志物
粪便隐血
联合检验
Colorectal cancer
Tumor markers
Fecal occult blood
Combined detection
